Grant: MERIT - A phase II marker identification trial for TarcevaTM in second line NSCLC patients

  • Basic View
  • XML View
Project Title
MERIT - A phase II marker identification trial for TarcevaTM in second line NSCLC patients
 
Principal Investigator Ho, James Chung Man (Principal investigator)
Funding Year
2005/2006
 
Amount
154641
 
Start Date
06-07-2005
 
Expected Completion
05-10-2007
 
Status
On-going
 
Keywords MERIT
Sponsor Other projects
Grant Type/Funding Scheme F Hoffmann-La Roche and Co. Ltd. - General Award
Duration
27
 
[Coming Soon]